[go: up one dir, main page]

CA2182188A1 - Substance pour application transdermique contenant du 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol - Google Patents

Substance pour application transdermique contenant du 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol

Info

Publication number
CA2182188A1
CA2182188A1 CA002182188A CA2182188A CA2182188A1 CA 2182188 A1 CA2182188 A1 CA 2182188A1 CA 002182188 A CA002182188 A CA 002182188A CA 2182188 A CA2182188 A CA 2182188A CA 2182188 A1 CA2182188 A1 CA 2182188A1
Authority
CA
Canada
Prior art keywords
alpha
agent
gestagen
optionally
triene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002182188A
Other languages
English (en)
Inventor
Clemens Gunther
Ralph Lipp
Ulrich Tauber
Jutta Riedl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002182188A priority Critical patent/CA2182188A1/fr
Publication of CA2182188A1 publication Critical patent/CA2182188A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette substance pour application transdermique se caractérise par le fait qu'elle contient du 14.alpha.,17.alpha.-éthanoestra-1,3,5(10)-triène-3,17.beta.-diol, en association avec un ou deux progestatif(s) le cas échéant.
CA002182188A 1994-01-27 1994-01-27 Substance pour application transdermique contenant du 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol Abandoned CA2182188A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002182188A CA2182188A1 (fr) 1994-01-27 1994-01-27 Substance pour application transdermique contenant du 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002182188A CA2182188A1 (fr) 1994-01-27 1994-01-27 Substance pour application transdermique contenant du 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol

Publications (1)

Publication Number Publication Date
CA2182188A1 true CA2182188A1 (fr) 1995-08-03

Family

ID=4158670

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002182188A Abandoned CA2182188A1 (fr) 1994-01-27 1994-01-27 Substance pour application transdermique contenant du 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol

Country Status (1)

Country Link
CA (1) CA2182188A1 (fr)

Similar Documents

Publication Publication Date Title
US5788984A (en) Gestodene-containing agent for transdermal administration
AU687013B2 (en) Transdermal application agent containing 3-keto-desogestrel
US5858394A (en) Agent for transdermal administration that contains gestodene esters
US5904931A (en) Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide
AU652121B2 (en) Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
CA2183544A1 (fr) Agent d'application transdermique contenant du desogestrel
RU2044541C1 (ru) Способ получения лечебного средства для трансдермального применения
JPH11509222A (ja) １３−エチル−１７β−ヒドロキシ−１１−メチレン−１８，１９−ジノル−１７α−プレグン−４−エン−２０−イン−３−オンのエステルを含む経皮投与のための剤
JP3034600B2 (ja) ロリプラムを含有する皮膚浸透移行性適用剤
CA2182188A1 (fr) Substance pour application transdermique contenant du 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol
JPH09510697A (ja) １４α，１７α−エタノエストラ−１，３，５（１０）−トリエン−３，１７β−ジオールを含有する経皮投与のための薬剤
DE4240806A1 (de) Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol
AU724308B2 (en) Transdermal therapeutic systems that contain sex steroids
HUT74616A (en) Agent, intended for transdermal administration, containing 14alfa, 17alfa-ethanoestra-1,3,5(10)-triene-3,17beta-diol

Legal Events

Date Code Title Description
FZDE Discontinued